FI Fast Break audio news: Aug. 28, 2024
The latest FI Fast Break news podcast discusses another noteworthy bankruptcy filing in the restaurant sector.
Tag: Eli Lilly
Analysis: Ozempic Likely to Impact Snack Manufacturers’ Bottom Line
The recent rise of Ozempic and other weight-loss drugs started with blowout results that drove shares of their manufacturers higher, then wound up cascading across seemingly disparate sectors. In 2023, Novo Nordisk, the manufacturer of …
Zepbound: Latest Weapon in Weight-Loss Drug Arsenal
Eli Lilly’s Zepbound, recently approved by the FDA, is the most potent weight-loss drug yet. Could it impact the food industry? At least one expert says ‘yes.’
Ozempic & Other Drugs: Explaining the Weight-Loss Medication Craze
Several medications approved to treat diabetes are being used as “miracle” weight-loss drugs, and the category continues to grow.